🔗 Share this article

An underground economy for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.

Investigational Drug Acquiring Popularity Online

The experimental drug, which remains in research studies, is being promoted by social media influencers for its supposed fat-burning properties. Viewers are encouraged to message these accounts directly for supplier links, while also obtaining promotional offers.

Thriving Trade on Messaging Platforms

Additionally, a flourishing trade exists on Telegram, where communities with thousands of participants share comparison images, administration instructions and assertions of next-day UK delivery. Sellers promote the substance there before directing customers to other platforms for transactions.

Learning About The Experimental Drug

This medication is an experimental injection developed by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could assist patients lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the next Ozempic.

Healthcare Experts Voice Worries

Nevertheless, physicians and chemists have warned that the sale of what is still an unapproved drug in the United Kingdom is a cause for concern and could result in individuals injecting substances of unknown origin.

Several experts said the demand for retatrutide could be linked to the rising price of approved slimming treatments such as Mounjaro.

Legal Position and Enforcement

Selling retatrutide on social media or messaging apps is illegal in the United Kingdom, as it is an unlicensed drug that must not be marketed or distributed for personal consumption under the British medical regulations.

Several content creators attempt to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still breach medicines, marketing, and customer laws, risking penalties, prosecution or imprisonment.

Service Reaction and Content Elimination

Based on TikTok, the service has removed problematic material and banned related hashtags and search suggestions. The company stated it was dedicated to keeping the service safe and allocating resources in strengthening enforcement strategies.

Digital Marketplace Activities

Research also found communities with up to 9,000 participants selling retatrutide using Telegram's integrated search feature, which functions like a public directory. Typing “retatrutide” immediately displays groups with thousands of users, filled with photos of weight loss, glowing reviews and detailed guides for preparing or injecting at home.

After minutes of joining one group, a vendor shared contact information, where the majority of transactions take place. The vendor sent an instruction manual and promised shipping within two days. When questioned whether the product was authentic, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None inquired about body mass, medical conditions or past usage.

Item Information and Pricing

Within these communities, posts show dark colored parcels with postal service labels, stating to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at residence with sterile water, or ready-to-use pens typically priced at £160 for 20 milligrams. When asked how long a pen should be used, vendors give contradictory answers ranging from a several days to “depends on your body”.

Service Moderation and Security Measures

A spokesperson for the messaging service stated it actively monitored harmful material on its service including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are administering substances they cannot confirm. Even if the research behind this drug is sound, these digital versions may not include what they claim,” said Jason Murphy, the head of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor linked the increase in interest to recent price rises for approved weight-loss medications such as Mounjaro. “With prices rising, patients are turning to social media. But counterfeit injections are highly risky. You cannot know what’s contained or whether the environment they were produced in was sterile,” she said.

Her team has already encountered patients injured by self-injection from unconfirmed sources. “We understand the frustration, but buying from messaging apps or WhatsApp is taking chances with your well-being,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Statement

A representative from the pharmaceutical company stated retatrutide was in phase 3 clinical trials and had not been reviewed or authorized by any government authority globally. “Consequently at this point no one can market [it] for personal consumption,” they explained, noting that any item “misleadingly claiming itself as a company investigational product not yet authorized … may expose users to potentially serious health risks”.